Decreased expression of protectin (CD59) in gut epithelium in ulcerative colitis and Crohn's disease

Human Pathology

Volumn 30, Issue 12, 1999, Pages 1427-1430

  Scheinin, Tom ^a   Böhling, Tom ^b   Halme, Leena ^b   Kontiainen, Sirkka ^b   Bjørge, Line ^b   Meri, Seppo ^b  

^a Surgical Hospital   (Finland)

^b NONE

Author keywords

CD59; Gut epithelium; IBD; Protectin

Indexed keywords

CD59 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL PROTECTION; CLINICAL ARTICLE; COLON MUCOSA; COMPLEMENT SYSTEM; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; MALE; MONONUCLEAR CELL; SMOOTH MUSCLE; ULCERATIVE COLITIS; VASCULAR ENDOTHELIUM;

EID: 0033428117     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90163-6     Document Type: Article

References (18)

1. Meri S: Protectin (CD59): Complement lysis inhibitor and prototype domain in a new protein superfamily. Immunologist 2:149-155, 1994
2. Nose M, Katoh M, Okada N, et al: Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology 70:145-149, 1990
3. Meri S, Waldmann H, Lachmann PJ: Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest 65:532-537, 1991
4. Väkevä A, Laurila P, Meri S: Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Lab Invest 67:608-616, 1992
5. Koretz K, Brüderlein S, Henne C, et al: Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium. Br J Cancer 68:926-931, 1993
6. Bjørge L, Vedeler CA, Ulvestad E, et al: Expression and function of CD59 on colonic adenocarcinoma cells. Eur J Immunol 24:1597-1603, 1994
7. Holguin MH, Frederick LR, Bernshaw NJ, et al: Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 84:7-17, 1989
8. Takeda J, Miyata T, Kawagoe K, et al: Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703-711, 1993
9. Venneker GT, Das PK, Meinardi MM, et al: Glycosylphosphatidyl-inositol (GPI)-anchored membrane proteins are constitutively downregulated in psoriatic skin. J Pathol 172:189-197, 1994
10. Selby WS, Janossy G, Bofill M, et al: Intestinal lymphocyte subpopulations in inflammatory bowel disease: An analysis by immunohistochemical and cell isolation techniques. Gut 25:32-40, 1984
11. Kett K, Rognum TO, Brandtzaeg P: Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology 93:919-924, 1987
12. Hodgson HJF, Potter BJ, Jewell DP: Humoral immune system in inflammatory bowel disease. I. Complement levels. Gut 18:749-753, 1977
13. Lake AM, Stitzel AE, Urmson JR, et al: Complement alter-ations in inflammatory bowel disease. Gastroenterology 76:1374-1379, 1979
14. Potter BJ, Hodgson HJF, Mee AS, et al: Clq metabolism in ulcerative colitis and Crohn's disease. Gut 20:1012-1019, 1979
15. Halstensen TS, Das KM, Brandtzaeg P: Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. Gut 34:650-657, 1993
16. Kitano A, Matsumoto T, Nakamura S, et al: New treatment of ulcerative colitis with K-76. Dis Colon Rectum 35:560-567, 1992
17. Uesu T, Mizuno M, Inoue H, et al: Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis. Lab Invest 72:587-591, 1995
18. Berstad AE, Brandtzaeg P: Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract. Gut 42:522-529, 1998